GPT Healthcare Q1 Results Reported Total Income of 10,005.59 Lakhs with PAT of 996.45 Lakhs

GPT Healthcare Q1 Results: GPT Healthcare has announced its Q1 results for FY 2024-2025, showing a steady performance compared to the previous quarter (QoQ). Revenue from operations for the quarter ended June 30, 2024, stood at ₹9,781.98 lakhs, a slight decrease of 1.62% QoQ compared to ₹9,942.58 lakhs in Q4 of FY 2023-2024.

However, other income rose by 40.47% QoQ, contributing to total income reaching ₹10,005.59 lakhs, a marginal decline of 0.95% QoQ from the previous quarter. Year-over-year (YoY) comparisons indicate a stable growth trajectory, with revenue holding steady as GPT Healthcare focuses on expanding its services and bed capacity.

On the expenses side, the company managed to reduce its material costs by 11.75% QoQ, with total expenses reaching ₹8,538.70 lakhs, reflecting a slight increase of 3.37% QoQ due to higher employee benefit expenses and other operational costs.

Profit before tax decreased by 20.32% QoQ, dropping from ₹1,841.43 lakhs in Q4 to ₹1,466.89 lakhs in Q1. After accounting for taxes, the company reported a net profit of ₹996.45 lakhs, down 22.26% QoQ.

For More Q1 results check our Twitter Page

GPT Healthcare Q1 Results 2024 - 2025

GPT Healthcare has released its Q1 financial results for the fiscal year 2024-2025, showing mixed performance. While there was a slight drop in revenue from operations, the company saw a notable improvement in other income.

Below is a detailed comparison of the key financial metrics for the quarter ended June 30, 2024, against the previous quarter.

Source: Click Here

GPT Healthcare Current Market Overview

GPT Healthcare is currently trading at ₹186 per share, with a market cap of ₹1,526 crores. The stock has seen a 52-week high of ₹220 and a low of ₹129, showing some volatility over the past year. With a Price-to-Earnings (P/E) ratio of 32.0, it indicates that investors are paying a premium for the stock.

The company has a solid Return on Capital Employed (ROCE) of 30.3% and a Return on Equity (ROE) of 24.9%, reflecting its strong financial performance. Additionally, it offers a dividend yield of 1.34%, making it attractive for income-seeking investors.

Quarterly Results

Here is a summary of GPT Healthcare's key financial data for the quarters ending in December 2023, March 2024, and June 2024. These figures highlight the company's performance across sales, expenses, and profit margins during the specified quarters.

About GPT Healthcare

GPT Healthcare is a healthcare company based in Kolkata, India, that operates a chain of multispecialty hospitals under the brand name ILS Hospitals. Founded in 2000, the company provides a wide range of medical, surgical, and emergency services across its four hospitals located in Kolkata, Agartala, Dumdum, and Howrah.

With over 560 beds currently, GPT Healthcare aims to grow to 1,000+ beds in the next three years. The company is committed to delivering high-quality healthcare to people of all socio-economic backgrounds, and it also runs pharmacies and a nursing institute in Agartala.

Check our website for more Q1 results.